Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19
Clinical trial NCT05516550 · UNKNOWN
Trial details
- NCT number
- NCT05516550
- Sponsor
- PHARMENTERPRISES LLC
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2022-12-01
- Enrollment
- 412
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.